This inventor holds 7 USPTO granted patents and 3 published patent applications. Top assignee: Columbia University. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Innovations in Nucleotide Sequencing by Cheng Guo
Introduction
Cheng Guo is a prominent inventor based in Brooklyn, NY, known for his significant contributions to the field of nucleotide sequencing. With a total of six patents to his name, Guo has made remarkable advancements that enhance the methods used in genetic research and biotechnology.
Latest Patents
Among his latest patents, Guo has developed innovative nucleotide derivatives and methods of use thereof. These patents disclose compounds, compositions, and methods that facilitate the sequencing of nucleic acids. Another notable patent focuses on the synthesis of novel disulfide linker-based nucleotides, which serve as reversible terminators for DNA sequencing by synthesis. These advancements are crucial for improving the efficiency and accuracy of genetic sequencing techniques.
Career Highlights
Cheng Guo is affiliated with Columbia University, where he conducts research and develops new technologies in the field of molecular biology. His work has garnered attention for its potential applications in various scientific and medical fields, particularly in genomics and personalized medicine.
Collaborations
Guo collaborates with esteemed colleagues, including Jingyue Ju and Xiaoxu Li, who contribute to his research endeavors. Their combined expertise fosters an environment of innovation and discovery, further enhancing the impact of their work in nucleotide sequencing.
Conclusion
Cheng Guo's contributions to nucleotide sequencing through his patents and research at Columbia University highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in genetic research and biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
